UPDATE 1-Hyperion stops diabetes drug development, shares fall

Sept 8 (Reuters) - Hyperion Therapeutics Inc said it would stop development of a diabetes drug following discovery of unlawful conduct by some employees of a recently acquired subsidiary, sending its shares down 25 percent premarket.